These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 162863)

  • 1. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.
    Yuhas JM; Pazmiño NH; Wagner E
    Cancer Res; 1975 Jan; 35(1):237-41. PubMed ID: 162863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma.
    Yuhas JM; Toya RE; Wagner E
    Cancer Res; 1975 Jan; 35(1):242-4. PubMed ID: 1109793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
    Yuhas JM; Pazmino NH; Proctor JO; Toya RE
    Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.
    Yuhas JM; Pazmiño NH
    Cancer Res; 1974 Aug; 34(8):2005-10. PubMed ID: 4366938
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
    Nomi S; Naito K; Kahan BD; Pellis NR
    Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a tumor cell surface protein with heterologous antisera to a spontaneous BALB/c lung carcinoma.
    Kennel SJ
    Cancer Res; 1979 Aug; 39(8):2934-9. PubMed ID: 222438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.
    Miller PW; Sharma S; Stolina M; Chen K; Zhu L; Paul RW; Dubinett SM
    Cancer Gene Ther; 1998; 5(6):380-9. PubMed ID: 9917093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of highly metastatic human tumor cell line in nude mice].
    Wu BQ
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):324-8. PubMed ID: 3004853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental model for evaluation of factors in tumor escape from immunological attack.
    Yutoku M; Fuji H; Grossberg AL; Pressman D
    Cancer Res; 1975 Mar; 35(3):734-9. PubMed ID: 1116132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
    Arkhipov SA; Iunker VM; Gruntenko EV
    Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
    Ullrich RL; Adams LM
    Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
    Milas L; Hersh EM; Stringfellow DA; Hunter N
    J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.